BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 24817179)

  • 1. Antiplasmodial activity study of angiotensin II via Ala scan analogs.
    Silva AF; Bastos EL; Torres MD; Costa-da-Silva AL; Ioshino RS; Capurro ML; Alves FL; Miranda A; Vieira Rde F; Oliveira VX
    J Pept Sci; 2014 Aug; 20(8):640-8. PubMed ID: 24817179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidences for the action mechanism of angiotensin II and its analogs on Plasmodium sporozoite membranes.
    Torres MD; Silva AF; Alves FL; Capurro ML; Miranda A; Cordeiro RM; Oliveira Junior VX
    J Pept Sci; 2016 Mar; 22(3):132-42. PubMed ID: 26856687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the angiotensin II Ala-scan analogs in erythrocytic cycle of Plasmodium falciparum (in vitro) and Plasmodium gallinaceum (ex vivo).
    Silva AF; de Souza Silva L; Alves FL; Der TorossianTorres M; de SáPinheiro AA; Miranda A; LaraCapurro M; Oliveira VX
    Exp Parasitol; 2015 Jun; 153():1-7. PubMed ID: 25720804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New linear antiplasmodial peptides related to angiotensin II.
    Silva AF; Torres MD; Silva Lde S; Alves FL; Pinheiro AA; Miranda A; Capurro ML; Oliveira VX
    Malar J; 2015 Nov; 14():433. PubMed ID: 26537730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly potential antiplasmodial restricted peptides.
    Marcelo Der Torossian T; Silva AF; Alves FL; Capurro ML; Miranda A; Vani Xavier O
    Chem Biol Drug Des; 2015 Feb; 85(2):163-71. PubMed ID: 24800635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of the anti-plasmodium activity of angiotensin II analogs.
    Chamlian M; Bastos EL; Maciel C; Capurro ML; Miranda A; Silva AF; Torres MD; Oliveira VX
    J Pept Sci; 2013 Sep; 19(9):575-80. PubMed ID: 23893516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II restricted analogs with biological activity in the erythrocytic cycle of Plasmodium falciparum.
    Torres MD; Silva AF; de Souza Silva L; de Sá Pinheiro AA; Oliveira VX
    J Pept Sci; 2015 Jan; 21(1):24-8. PubMed ID: 25420772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-plasmodial activity of bradykinin and analogs.
    Silva AF; Alves FL; Pedron CN; Torres MD; Silva LS; Pinheiro AA; Miranda A; Oliveira VX
    Bioorg Med Chem Lett; 2015 Aug; 25(16):3311-3. PubMed ID: 26077496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological and conformational evaluation of angiotensin II lactam bridge containing analogues.
    Oliveira VX; Fázio MA; Silva AF; Campana PT; Pesquero JB; Santos EL; Costa-Neto CM; Miranda A
    Regul Pept; 2011 Dec; 172(1-3):1-7. PubMed ID: 21787808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II-derived constrained peptides with antiplasmodial activity and suppressed vasoconstriction.
    Silva AF; Torres MT; Silva LS; Alves FL; de Sá Pinheiro AA; Miranda A; Capurro ML; de la Fuente-Nunez C; Oliveira VX
    Sci Rep; 2017 Oct; 7(1):14326. PubMed ID: 29085013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Net charge tuning modulates the antiplasmodial and anticancer properties of peptides derived from scorpion venom.
    Pedron CN; Silva AF; Torres MT; Oliveira CS; Andrade GP; Cerchiaro G; Pinhal MAS; de la Fuente-Nunez C; Oliveira Junior VX
    J Pept Sci; 2021 Apr; 27(4):e3296. PubMed ID: 33442881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-plasmodium activity of angiotensin II and related synthetic peptides.
    Maciel C; de Oliveira Junior VX; Fázio MA; Nacif-Pimenta R; Miranda A; Pimenta PF; Capurro ML
    PLoS One; 2008 Sep; 3(9):e3296. PubMed ID: 18820728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Electron microscopic observation of the sporogonic stage of Plasmodium gallinaceum after five antimalarials].
    Hu CR; Chen PH; Chen JM; Huang Q
    Zhongguo Yao Li Xue Bao; 1989 Sep; 10(5):434-7. PubMed ID: 2618732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of some new angiotensin II analogs on the reactivity of small arterioles in the mesentery of rat intestine.
    Folwarczna J; Janiec W; Sliwiński L; Paruszewski R
    Pol J Pharmacol Pharm; 1989; 41(6):585-9. PubMed ID: 2485905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of renal angiotensin II receptors using subtype selective antagonists.
    Edwards RM; Stack EJ; Weidley EF; Aiyar N; Keenan RM; Hill DT; Weinstock J
    J Pharmacol Exp Ther; 1992 Mar; 260(3):933-8. PubMed ID: 1545405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin antagonists with increased specificity for the renal vasculature.
    Taub KJ; Caldicott WJ; Hollenberg NK
    J Clin Invest; 1977 Mar; 59(3):528-35. PubMed ID: 190270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced angiotensin II-induced activation of Na+, K+-ATPase in the proximal tubules of obese Zucker rats.
    Shah S; Hussain T
    Clin Exp Hypertens; 2006 Jan; 28(1):29-40. PubMed ID: 16443562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of chlorovinyl sulfones as structural analogs of chalcones and their antiplasmodial activities.
    Dominguez JN; Leon C; Rodrigues J; Gamboa de Dominguez N; Gut J; Rosenthal PJ
    Eur J Med Chem; 2009 Apr; 44(4):1457-62. PubMed ID: 19036479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organ specificity of angiotensin II and Des-aspartyl angiotensin II in the conscious rat.
    Campbell WB; Pettinger WA
    J Pharmacol Exp Ther; 1976 Aug; 198(2):450-6. PubMed ID: 948036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and in vitro antiplasmodial activities of fluoroquinolone analogs.
    Dixit SK; Mishra N; Sharma M; Singh S; Agarwal A; Awasthi SK; Bhasin VK
    Eur J Med Chem; 2012 May; 51():52-9. PubMed ID: 22424611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.